AbbVie
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
AbbVie (ABBV) SEC Filings
Browse all AbbVie SEC filings, including Annual reports (10-K), Quarterly reports (10-Q), 8-K, proxy statements (DEF 14A), and insider filings (Form 4). Access official documents by filing date, reporting period, and form type. ...more
AbbVie Reports: Annual 10-K, Quarterly 10-Q & SEC Filings
SEC Filings
Date
2026
8-K
Material company events (earnings, M&A, or leadership changes)
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
SC 13G/A
Updated passive ownership disclosure
SC 13G/A
Updated passive ownership disclosure
DEF 14A
Final shareholder voting details (board elections and executive pay)
DEFA14A
Additional or supplemental proxy disclosures
ARS
Annual Report to Shareholders
4/A
Correction to a previously reported insider transaction
PRE 14A
Preliminary proxy statement filed for SEC review
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
8-K
Material company events (earnings, M&A, or leadership changes)
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
FWP
Free writing prospectus related to a securities offering
424B5
Shelf offering prospectus with final pricing terms
8-K
Material company events (earnings, M&A, or leadership changes)
FWP
Free writing prospectus related to a securities offering
424B5
Shelf offering prospectus with final pricing terms
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
4
Insider ownership (buying, selling) activity
10-K
Annual financial results and management updates
8-K
Material company events (earnings, M&A, or leadership changes)
8-K
Material company events (earnings, M&A, or leadership changes)
AbbVie (Form 8-K) 2026
Current Events / Material company events (earnings, M&A, or leadership changes)
Apr 3, 2026
